Home » Newsletters » BioWorld

BioWorld

Feb. 22, 1993

View Archived Issues

ESCAGENETICS DEAL FOR DATE PALM

APPOINTMENTS AND ADVANCEMENTS

U.K. FIRMS FIND GREENER PASTURES IN U.S.

STOCKS CONTINUE TO SLIDE

REGENERON'S CNTF PATENT ALLOWED

VIRAL TESTING GETS DISTRIBUTION RIGHTS

ISIS REPORTS PRECLINICAL RESULTS

CHANGES AFOOT ON LONDON EXCHANGE

CHEMEX STUDY OF PSORIASIS DRUG

BONDS SOLD FOR ALPHA-BETA FACILITY

AFRICAN SWEET POTATOES TAUGHT TO FIGHT VIRUS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 11, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 11, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Flow Neuro wins FDA nod for at-home device for depression
BioWorld MedTech
Flow Neuroscience AB received U.S. FDA 510(k) approval for its Flow at-home brain-stimulation device to treat major depressive disorder. The wearable headset uses...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...